Evidence map›Paper›PMID 41045259›Full record

ArticleHuman vaccines & immunotherapeutics2025

CIMT 2025: Report on the 22

Lia Dahl, Johanna Kiefer, Laura Klein, Sophie-Christin Linkenbach, Anindhita Meena Muralidharan, Matthias Peter, Nina Tagscherer, Jan D Beck

Abstract readConference Proceedings
In one paragraph

Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lia DahlBioNTech Cell & Gene Therapies GmbH, Mainz, Germany.
Johanna KieferBioNTech SE, Mainz, Germany.
Laura KleinBioNTech SE, Mainz, Germany.
Sophie-Christin LinkenbachTRON-Translational Oncology, University Medical Center of Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.
Anindhita Meena MuralidharanTRON-Translational Oncology, University Medical Center of Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.
Matthias PeterTRON-Translational Oncology, University Medical Center of Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.
Nina TagschererTRON-Translational Oncology, University Medical Center of Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.
Jan D BeckBioNTech SE, Mainz, Germany.ORCID 0000-0002-0379-1915

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 22

Indexed as

ImmunotherapyNeoplasmsAntigens, NeoplasmGermanyHumansAntigens, Neoplasmcancer immunotherapycellular therapyCIMTpersonalized therapytumor microenvironment

Identifiers

PMID41045259
PMCPMC12498539

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.